2
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: not found
      • Article: not found

      Pharmacoeconomic Review Report for Nusinsersin; Appendix 1, Cost Comparison. Nusinersen (Spinraza): (Biogen Canada Inc.): Indication: Treatment of patients with 5q SMA. CADTH Common Drug Review

      Read this article at

      ScienceOpen
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Related collections

          Comments

          Comment on this article